Recinos-Money E, Escobar-Alfaro G, Contreras J, Zepeda-Castilla E, Parra-Torres C, Di Castro P

Language: Spanish
References: 27
Page: 71-75
PDF size: 119.70 Kb.

ABSTRACT

Background: Adenosarcomas are rare tumors and are usually derived from the endometrium. About 50 cases of adenosarcomas of the ovary have been reported. The relation between adenosarcoma and CA125 has not been described. The authors present a case of adenosarcoma with elevated CA125 because of the unusual presentation of this pathology and also because elevation of the CA125 antigen is not reported in the literature.
Clinical case: A 42-year-old woman presented for consultation for incidental right ovarian tumor and CA125 of 1,100 U/ml. Histology revealed a homologous Müllerian adenosarcoma of the right ovary, with sarcomatous overgrowth. CA125 decreased to 16 U/ml after surgery. Sixteen months post-surgery, the patient is disease free and with normal CA125.
Discussion: Ovarian adenosarcomas are more aggressive than adenosarcomas of the uterus. Because of the embryological origin, ovarian adenosarcomas are able to produce CA125 antigen, especially in the presence of sarcomatous overgrowth. With these facts, CA125 antigen may be useful as a prognostic factor because it may represent an indirect marker of sarcomatous overgrowth.
Conclusions: CA125 may be useful for follow-up of ovarian adenosarcomas. Elevated CA125 antigen in adenosarcomas of the ovary may be indicative of sarcomatous overgrowth and poor prognosis.

REFERENCES

1. 1. Clement PB, Scully RE. Müllerian adenosarcoma of the uterus: a clinicopathologic analysis of 100 cases with a review of the literature. Hum Pathol 1990;21:363-381.

2. 2. Clement PB, Scully RE. Müllerian adenosarcoma of the uterus: a clinicopathologic analysis of ten cases of a distinctive type of Müllerian mixed tumor. Cancer 1974;34:1138-1149.

3. 3. Eichhorn JH, Young RH, Clement PB, Scully RE. Mesodermal (Müllerian) adenosarcoma of the ovary: a clinicopathologic analysis of 40 cases and a review of the literature. Am J Surg Pathol 2002;26:1243-1258.

4. 4. Dellers EA, Valente PT, Edmonds PR, Balsara G. Extrauterine mixed mesodermal tumors: an immunohistochemical study. Arch Pathol Lab Med 1981;115:918-920.

5. 5. Kao GF, Norris HJ. Benign and low grade variants of mixed mesodermal tumor (adenosarcoma) of the ovary and adnexal region. Cancer 1978;42:1314-1324.

6. 6. Valdez VA, Planas AT, Lopez VF, Goldberg M, Herrera NE. Adenosarcoma of the uterus and ovary: a clinicopathologic study of two cases. Cancer 1979;43:1439-1447.

7. 7. Inoue M, Fukuda H, Tanizawa O. Adenosarcoma originating from sites other than uterine endometrium. Int J Gynecol Obstet 1995;48:299-306.

8. 8. Fukunaga M, Nomura K, Endo Y, Ushigome S, Aizawa S. Ovarian adenosarcoma. Histopathology 1997;30:283-287.

9. 9. Hirakawa E, Kobayashi S, Miki H, et al. Ascitic fluid cytology in adenosarcoma of the ovary: a case report. Diagn Cytol 2001;24:343-346.

10. 10. Clemet PB, Scully RE. Extrauterine mesodermal (Müllerian) adenosarcoma. A clinicopathologic analysis of five cases. Am J Clin Pathol 1978;69:276-283.

11. 11. Gollard R, Kosty M, Bordin G, Wax A, Lacey C. Two unusual presentations of Müllerian adenosarcoma: case report, literature review, and treatment considerations. Gynecol Oncol 1995;59:412-422.

12. 12. Kwok A, Lam A, Ford R. Deeply infiltrating endometriosis: implications, diagnosis and management. Obstet Gynecol Surv 2001;58:168-177.

13. 13. Millares C, Orea M, España P, et al. Cancer antigen 125 associated with multiple benign and malignant pathologies. Ann Surg Oncol 2003;10:150-154.

14. 14. Parker RL, Dadmanesh F, Young RH, Clement PB. Polypoid endometriosis: a clinicopathologic analysis of 24 cases and a review of the literature. Am J Surg Pathol 2004;28:285-297.

15. 15. Östör AG, Nirenberg A, Ashdown ML, Murphy DJ. Extragenital adenosarcoma arising in the pouch of Douglas. Gynecol Oncol 1994;53:373-375.

16. 16. Hines BJ, Porges RF, Mittal K, Muggia FM, Curtin JP. Use of medroxyprogesterone acetate in the treatment of Müllerian adenosarcoma: a case report. Gynecol Oncol 2002;85:192-195.

17. 17. De Jonge MJ, Van Dam PA, Van Marck E, Prove A, Van Oosterom AT. Primary extrauterine Müllerian adenosarcoma of the peritoneum. Gynecol Oncol 1995;57:126-130.

18. 18. World Health Organization Classification of Tumours. In: Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Tavassoli FA, Devilee P, eds., Lyon: IARC Press;2003. pp. 114-115.

19. 19. Hirschfield L, Kahn LB, Chen S, Winkler B, Rosenberg S. Müllerian adenosarcoma with ovary sex cord-like differentiation: a light- and electron-microscopic study. Cancer 1986;57:1197-1200.

20. 20. Kerner H, Lichtig C, Beck D. Extrauterine Müllerian adenosarcoma of the mesothelium: a clinicopathologic and electron microscopic study. Obstet Gynecol 1989;73:510-513.

21. 21. Benda JA, Veronezi-Gurwell A, Wilcox M, Buller R. An unusual extrauterine variant of adenosarcoma with multiple recurrences over 16 years. Gynecol Oncol 1994;53:131-137.

22. 22. Russell P, Slavutin L, Laverty CR, Cooper-Booth J. Extrauterine mesodermal (Müllerian) adenosarcoma. A case report. Pathology 1979;11:557-560.

23. 23. Scully RE, Young RH, Clement PB. Endometrioid tumors. In: Tumors of the Ovary, Maldeveloped Gonads, Fallopian Tube, and Broad Ligament. Atlas of Tumor Pathology, Third series. Fascicle 23. Washington: AFIP;1998. pp. 107-140.

24. 24. Prat J. Pathology of the Ovary. Philadelphia: Elsevier;2004. pp. 145-147.

25. 25. Michener CM, Simon NL. Ovarian conservation in a woman of reproductive age with Müllerian adenosarcoma. Gynecol Oncol 2001;83:424-427.

26. 26. Kaku T, Silverberg SG, Major FJ, Miller A, Fetter B, Brady MF. Adenosarcoma of the uterus: a gynecologic oncology group clinicopathologic study of 31 cases. Int J Gynecol Pathol 1992;11:75-88.

27. 27. Seidman JD, Chauhan S. Evaluation of the relationship between adenosarcoma and carcinosarcoma and a hypothesis of the histogenesis of uterine sarcomas. Int J Gynecol Pathol 2003;22:75-82.